PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Tosei General Hospital, Seto, Japan. Electronic address: infection-travel@tosei.or.jp.\', \'Department of Infection Control Team, Tosei General Hospital, Seto, Japan.\', \'Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.\', \'Department of Infectious Diseases, Tosei General Hospital, Seto, Japan; Department of Infection Control Team, Tosei General Hospital, Seto, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(21)00333-010.1016/j.jiac.2021.11.022
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34863647
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34863647>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34863647>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all